Latham & Watkins LLP represented Crossover Health in the transaction. Crossover Health, a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for […]
Crossover Health’s $168 Million Series D Financing
Enovix’s $1.128 Billion Merger with Rodgers Silicon Valley Acquisition Corp
Latham & Watkins LLP represented Eclipse Ventures in the transaction. Enovix Corporation, the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, […]
Owlet Baby Care’s $1.39 Billion Merger with Sandbridge Acquisition Corporation
Latham & Watkins LLP advised Owlet Baby Care, while Ropes & Gray LLP advised Sandbridge on the deal. Owlet Baby Care Inc. and Sandbridge Acquisition Corporation […]
0x Labs’ $15 Million Series A Funding Round
Latham & Watkins LLP represented Pantera Capital in the transaction. 0x Labs, the firm behind a decentralized exchange (DEX) protocol and the ZRX token, has closed […]